BIOACTIVE PEPTIDE MARKET ANALYSIS

Bioactive Peptide Market, by Source (Plant, Milk, Eggs, Meat, Fish and Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)), by Therapeutic Area (Antihypertensive, Antioxidant, Immunostimulatory, Antimicrobial, Diabetes, and Others( Gastrointestinal System and Cardiovascular System)), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others(Drug Store and Mail-Order Pharmacy)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Sep 2022
Code : CMI3018
Pages :167
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Bioactive Peptide Market: Key Developments

Increasing research and development by key market players in the global bioactive peptide market is expected to drive the global bioactive peptide market over the forecast period. For instance, in September 2020, NeoMatrix Therapeutics, Inc., a clinical-stage company, announced positive topline data from its Phase 1 clinical trial of NMT-cP12, a bioactive peptide for intravenous treatment of burns within 2 to 4 hours of injury.

Furthermore, increasing number of inorganic strategies such as product launch by market players is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, Rousselot, a collagen-based solutions, announced the launch of MSC-certified (Marine Stewardship Council) marine collagen peptides, Peptan, at Beauty & Skincare Formulation Conference 2021, which is made up of wild-caught marine white fish and certified by the Marine Stewardship Council (MSC) to help beauty and nutrition brands differentiate and expand their portfolio in nutria-cosmetics and dietary supplements.